首页> 外国专利> COMPOSITIONS AND METHODS FOR MESENCHYMAL/STROMAL STEM CELL REJUVENATION AND TISSUE REPAIR BY ENHANCED CO-EXPRESSION OF TELOMERASE AND MYOCARDIN

COMPOSITIONS AND METHODS FOR MESENCHYMAL/STROMAL STEM CELL REJUVENATION AND TISSUE REPAIR BY ENHANCED CO-EXPRESSION OF TELOMERASE AND MYOCARDIN

机译:通过增强端粒酶和肌卡丁共表达来恢复间质/间质干细胞和组织修复的组合物和方法

摘要

A major risk factor for ischemic heart disease is advanced age. In adult bone marrow and other tissues, the number and function of stem cells decline with aging. Telomerase reverse transcriptase (TERT) is a nuclear protein that decreases senescence. Myocardin (MYOCD) is a transcription factor for myogenesis. Thus a method is provided for the simultaneous delivery of the telomerase reverse transcriptase (TERT) and myocardin MYOCD genes that resuscitates mesenchymal stromal cells (MSCs) from aged adipose and bone marrow tissues by increasing their capacity for survival, proliferation, and differentiation. TERT+/MYOCD+ MSCs restores a capacity for repairing ischemic tissues via improved blood flow and revascularization.
机译:缺血性心脏病的主要危险因素是高龄。在成年骨髓和其他组织中,干细胞的数量和功能会随着衰老而下降。端粒酶逆转录酶(TERT)是减少衰老的核蛋白。心肌素(MYOCD)是肌发生的转录因子。因此,提供了一种用于同时递送端粒酶逆转录酶(TERT)和心肌MYOCD基因的方法,其通过增加衰老的脂肪和骨髓组织的存活,增殖和分化能力而使间充质基质细胞(MSC)复苏。 TERT + / MYOCD + MSC通过改善血流和血运重建来恢复缺血组织的修复能力。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号